Literature DB >> 7621561

Should serum calcitonin be measured routinely in all patients with nodular thyroid disease?

M C Sheppard1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7621561     DOI： 10.1111/j.1365-2265.1995.tb02661.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  2 in total

1.  A case of spurious hypercalcitoninemia: a cautionary tale on the use of plasma calcitonin assays in the screening of patients with thyroid nodules for neoplasia.

Authors:  G I Uwaifo; A T Remaley; M Stene; J C Reynolds; P M Yen; R H Snider; K L Becker; N J Sarlis
Journal:  J Endocrinol Invest       Date:  2001-05       Impact factor: 4.256

2.  Routine calcitonin measurement in nodular thyroid disease management: is it worthwhile?

Authors:  Yigit Turk; Ozer Makay; Murat Ozdemir; Gozde Ertunc; Batuhan Demir; Gokhan Icoz; Mahir Akyildiz; Mustafa Yilmaz
Journal:  Ann Surg Treat Res       Date:  2017-03-24       Impact factor: 1.859
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.